Avalon Technology Group Inc (AVLN) Stock Price

31.45 ▲ +2.14 (+7.30%)
Open: 29.60 Vol: 1.11M Day's range: 29.32 - 32.165 Jun 18, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AVLN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 31.38▲ 30.80▲ 30.63▲ 29.53▲ 29.24▲
MA10 31.11▲ 30.53▲ 30.21▲ 28.81▲ N/A    
MA20 30.87▲ 30.31▲ 29.64▲ 28.09▲ N/A    
MA50 30.51▲ 29.73▲ 29.45▲ N/A     N/A    
MA100 30.24▲ 29.41▲ 28.33▲ N/A     N/A    
MA200 29.69▲ 28.39▲ 28.54▲ N/A     N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.075▲ 0.088▲ 0.147▲ N/A     N/A    
RSI 61.769▲ 65.642▲ 66.336▲ 60.772▲ N/A    
STOCH 68.513     83.622▲ 69.957     63.403     N/A    
WILL %R -39.024     -19.444▲ -15.094▲ -9.147▲ N/A    
CCI 113.952▲ 185.384▲ 166.010▲ 155.796▲ N/A    
Latest Filters Detected On AVLN
▲ RSI&VOL $AVLN RSI Cross Up and Volume Set Alert
RSI $AVLN RSI(14) Crossed Above 50 Set Alert
MA $AVLN Price Crossed Above MA(26) Set Alert
MA $AVLN Price Crossed Above MA(7) Set Alert
CDL $AVLN Engulfing Candlestick Pattern Detected Set Alert
Avalon Technology Group Inc News
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
Wednesday, June 17, 2026 06:57 AM
Company expects to report topline 12-month clinical results in the second half of 2027BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) (Avalyn or the Company), a ...
Avalyn Pharma Inc.: Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
Wednesday, June 17, 2026 05:40 AM
Avalyn Pharma Inc. (Nasdaq: AVLN) (Avalyn or the Company), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment ...
Avalyn Pharma outlines inhaled fibrosis push after IPO, with pivotal data ahead
Friday, June 05, 2026 07:06 PM
Avalyn Pharma (NASDAQ:AVLN) executives outlined the company's inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies ...
AVLN historical stock data
date open high low close volume
18/06/26 29.60 32.165 29.32 31.45 1,107,812
17/06/26 28.02 31.14 28.00 29.31 539,281
16/06/26 28.26 29.78 28.00 28.07 382,426
15/06/26 29.98 32.185 28.37 28.75 273,870
12/06/26 28.17 30.45 27.37 30.08 284,768
11/06/26 28.25 28.945 27.655 28.07 199,615
10/06/26 29.00 31.00 28.47 28.53 341,316
09/06/26 28.19 29.41 27.255 28.67 199,412
08/06/26 27.62 29.00 26.195 28.06 272,294
05/06/26 27.19 29.40 25.775 27.06 326,037
Quote Details
52wk Low:24.15
52wk High:32.225
Vol:1.11M
Avg Vol(3m):5.5M
1Y Chng:+0.00%
1M Chng:+16.78%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.35B